Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

This study has been terminated.
(Reactogenicity met study halting criteria)
Sponsor:
Collaborator:
PATH
Information provided by (Responsible Party):
Karen Kotloff, University of Maryland
ClinicalTrials.gov Identifier:
NCT00866476
First received: March 19, 2009
Last updated: April 20, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 20, 2017